Results 181 to 190 of about 32,386 (229)

Interventions for maintenance of surgically induced remission in Crohn's disease: a systematic review and network meta-analysis. [PDF]

BMJ Open Gastroenterol
Gordon M, Liu S, Sinopoulou V, Albuquerque DAN, Moran G.   +4 more
europepmc   +1 more source

Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials. [PDF]

BMJ Open
Strand V, Schulze-Koops H, Al-Emadi S, Kinch CD, Gruben D, Germino R, Connell CA, Mysler E.   +7 more
europepmc   +1 more source

<i>HLA-C</i>*03:04:01 and <i>HLA-B</i>*15:18:01 but not <i>HLA-DQA1</i>*05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients. [PDF]

World J Gastroenterol
Weng MT, Yao CY, Lin WC, Lai SK, Tung CC, Wang CY, Wong JM, Chen PL, Wei SC.   +8 more
europepmc   +1 more source

Low satisfaction with medical care among patients with hidradenitis suppurativa: A multicenter study

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 2, Page e95-e99, February 2026.
Kerstin Wolk, Giorgia Cugno, Georgios Kokolakis, Sylke Schneider‐Burrus, Dagmar Wilsmann‐Theis, Katharina Assaf, Rotraut Moessner, Christian Kromer, Falk G. Bechara, Nessr Abu Rached, Wiebke K. Peitsch, Lisa C. Schneider, Andreas Happ, Valentina Siddi, Diana Kubitzki, Durdana Groß, Markus Friedrich, Staffan Vandersee, Khusru Asadullah, Robert Sabat   +19 more
wiley   +1 more source

Dual Targeted Therapy for Hidradenitis Suppurativa: A Narrative Review. [PDF]

Dermatol Ther (Heidelb)
Kherallah K, Chung CS, Ghanshani R, Charrow A, Riley JM, Sayed CJ, Shi VY, Lee KH, Hsiao JL.   +8 more
europepmc   +1 more source

Originator versus biosimilar adalimumab in hidradenitis suppurativa: A multicenter real-world analysis of clinical response, maintenance of response, and switching. [PDF]

JAAD Int
Aghajani M, Pham J, Sholji T, Burrell K, Kok C, Frew JW.   +5 more
europepmc   +1 more source

Immunogenicity of adalimumab in patients with noninfectious uveitis based on therapeutic drug monitoring. [PDF]

J Transl Med
Han JW, Zhou Y, Guo J, Chen X.
europepmc   +1 more source

Risk of tuberculosis and hepatitis B reactivation during adalimumab use in the treatment of hidradenitis suppurativa. [PDF]

Sci Rep
Karakoyun Ö, Ayhan E.
europepmc   +1 more source